Ingredient Guide · GLP-1 Cluster

Garcinia Cambogia (HCA) — Appetite Control & Fat Synthesis Inhibition

Beyond the hype: what the clinical evidence actually shows about hydroxycitric acid's role in fat synthesis inhibition and appetite regulation.

📖 ~7 min read🔬 Evidence-based🔗 Part of the GLP-1 cluster

Quick Summary

  • HCA inhibits citrate lyase — reduces fat synthesis from carbohydrates
  • Supports serotonin-mediated appetite and craving signalling
  • Systematic review: statistically significant weight reduction vs placebo
  • Most effective with consistent delivery — not acute single doses
  • Transdermal delivery avoids GI discomfort common with high-dose oral HCA

What Is Garcinia Cambogia?

Garcinia cambogia is a small tropical fruit native to Southeast Asia and India. Its active compound — hydroxycitric acid (HCA) — is extracted from the fruit rind. HCA's mechanisms are distinct from the AMPK pathway activated by berberine and EGCG, making it a genuinely complementary addition to a multi-compound metabolic formula.

500mgHCA equivalent dose in the Duori patch
Citrate Lyaseenzyme inhibited — reduces fat synthesis
Serotoninappetite pathway modulated by HCA

How HCA Works

Fat Synthesis Inhibition: Citrate lyase converts excess dietary carbohydrates into fatty acids for storage. HCA competitively inhibits this enzyme, reducing the conversion of citrate to acetyl-CoA — the precursor for fatty acid and cholesterol synthesis. By slowing fat synthesis from dietary carbohydrates, HCA shifts the metabolic balance toward fat oxidation.

Serotonin Modulation: HCA influences serotonin levels through mechanisms not fully characterised, but serotonin plays a key role in appetite regulation and satiety signalling. Higher serotonin activity is associated with reduced appetite and improved satiety — which may explain craving-reduction effects reported independently of the citrate lyase mechanism.

The controversy explained

Garcinia Cambogia was heavily over-marketed in the 2010s with unrealistic weight loss claims. The backlash was warranted — but it was directed at the marketing, not the mechanism. HCA has modest, specific effects on fat synthesis inhibition and appetite signalling. As part of a multi-compound formula targeting multiple pathways, its contribution is additive and real.

What the Evidence Shows

A 2011 systematic review of 12 randomised controlled trials found statistically significant reductions in body weight with Garcinia cambogia versus placebo — mean difference approximately 0.88kg over 12 weeks. Modest, but additive to the effects of berberine and EGCG rather than duplicative. In a multi-pathway formula, each compound's individual contribution compounds total effect.

Five complementary mechanisms — one morning patch

Berberine, Chromium, EGCG, Garcinia Cambogia, and Gymnema. The Duori GLP-1 Support Patch.

Frequently Asked Questions

HCA from Garcinia Cambogia has modest but real effects — systematic reviews find statistically significant weight reduction versus placebo. The historical issue was over-marketing, not mechanism failure. HCA is a supportive metabolic compound that works best as part of a multi-ingredient formula.
At standard doses, HCA is well-tolerated in clinical studies. High-dose oral supplements in the early 2000s were associated with rare adverse events, but those cases involved products with undisclosed adulterants. Pure HCA at studied doses has a clean safety profile in peer-reviewed literature.
Most clinical research used 1,000–3,000mg of Garcinia extract (50–60% HCA). The 500mg HCA equivalent in the Duori patch delivers this within a multi-ingredient formula where combined effect across five compounds is the relevant metric.

* These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.